Breaking News

You are here » Indian-Commodity  :  Corporate  :  RCom presents 'Zero Loan Write-off Plan' to lenders

31-Oct2017

RCom presents 'Zero Loan Write-off Plan' to lenders

Reliance Communications (RCom) has made a comprehensive debt resolution plan to its domestic and foreign Lenders. The company's debt resolution plan envisages no loan write-off by the lenders. RCom will pay off up to Rs 17,000 crore of its debt, out of the proceeds of monetization of Spectrum, Towers and Fiber and MCN (Media Convergence Nodes) assets. RCom will pay additional Rs 10,000 crore of its debt, out of the proceeds of sales and commercial development of DAKC and other prime real estate assets across 8-metros.

RCom is working closely with SBI Capital Markets, the advisors appointed by the Lenders, to run a competitive process in a transparent manner to monetize the Spectrum, Tower and Fiber, MCNs and prime real estate assets. The company will also monetize its extensive Tower and Fiber portfolio comprising of 43,000 plus towers and over 1,78,000 Route KM of Intercity and Intracity Fiber. The debt of Rs 7,000 crore is proposed to be converted into 51% of the company's equity, as per the SDR guidelines of the Reserve Bank of India.

Reliance Communications is India's foremost and truly integrated telecommunications service provider. The company has a customer base of around 75 million, including over 2.6 million individual overseas retail customers.



Related News

View all news

NCLT levies penalty on Tata Chemicals

The National Company Law Tribunal (NCLT) Mumbai, has levied a penalty of Rs 10 lakh on Tata Chemicals for filing a petition fraudulently and with malicious intent to liquidate Raj Process Equipment and......

Reliance Industries' arms to launch new e-commerce platform

Reliance Industries' group companies--Reliance Jio and Retail will launch a new e-commerce platform in the country. This project will empower 12 lakh small retailers in Gujarat.Reliance Industries is India's......

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......